Literature DB >> 8675573

Relationship between circulating insulin-like growth factor components and sex hormones in a population-based sample of 50- to 80-year-old men and women.

J Pfeilschifter1, C Scheidt-Nave, G Leidig-Bruckner, H W Woitge, W F Blum, C Wüster, D Haack, R Ziegler.   

Abstract

There is a large body of evidence that points to a systemic link between the somatotropic axis and sex hormones, but epidemiologic data on the interactions between the two hormonal systems are still missing. We examined here the associations between the plasma levels of insulin-like growth factor (IGF) I, IGF-II, IGF-binding protein 3 (IGFBP-3), and sex hormones in a population-based sample of 486 men and women, aged 50-80 yr. The strongest association was an age-independent inverse correlation between all three circulating IGF components and sex hormone-binding globulin (SHBG), the major testosterone-binding protein in plasma. Consistent with this, bio-available (non-SHBG-bound) but not total testosterone levels were positively associated with the IGF system in men, and 3 alpha-androstanediol glucuronide was positively correlated with circulating IGFs in women. Moreover, part of the correlation between the circulating IGF system and bone mineral density at the femur and the calcaneus could be accounted for by SHBG. Our data suggest that sex hormones and the GH/IGF system are significantly interrelated in the elderly population. These hormonal interactions may play an important role in human aging and the pathogenesis of age-related diseases.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8675573     DOI: 10.1210/jcem.81.7.8675573

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  19 in total

Review 1.  Hormone replacement therapy and physical function in healthy older men. Time to talk hormones?

Authors:  Manthos G Giannoulis; Finbarr C Martin; K Sreekumaran Nair; A Margot Umpleby; Peter Sonksen
Journal:  Endocr Rev       Date:  2012-03-20       Impact factor: 19.871

Review 2.  Dementia: a neuroendocrine perspective.

Authors:  A Polleri; M V Gianelli; G Murialdo
Journal:  J Endocrinol Invest       Date:  2002-01       Impact factor: 4.256

Review 3.  Insulin-Like growth factor I: implications in aging.

Authors:  E Arvat; F Broglio; E Ghigo
Journal:  Drugs Aging       Date:  2000-01       Impact factor: 3.923

4.  Relationships between cortisol, dehydroepiandrosterone sulphate and insulin-like growth factor-I system in dementia.

Authors:  G Murialdo; A Barreca; F Nobili; A Rollero; G Timossi; M V Gianelli; F Copello; G Rodriguez; A Polleri
Journal:  J Endocrinol Invest       Date:  2001-03       Impact factor: 4.256

5.  Association between endogenous sex steroid hormones and insulin-like growth factor proteins in US men.

Authors:  Stefania I Papatheodorou; Sabine Rohrmann; David S Lopez; Gary Bradwin; Corinne E Joshu; Norma Kanarek; William G Nelson; Nader Rifai; Elizabeth A Platz; Konstantinos K Tsilidis
Journal:  Cancer Causes Control       Date:  2014-01-07       Impact factor: 2.506

Review 6.  DHEA and the skeleton (through the ages).

Authors:  C M Gordon; J Glowacki; M S LeBoff
Journal:  Endocrine       Date:  1999-08       Impact factor: 3.633

7.  Calcaneum broadband ultrasound attenuation relates to vegetarian and omnivorous diets differently in men and women: an observation from the European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population study.

Authors:  Ailsa Welch; Sheila Bingham; Joanna Camus; Nichola Dalzell; Jonathan Reeve; Nick Day; K T Khaw
Journal:  Osteoporos Int       Date:  2004-10-05       Impact factor: 4.507

Review 8.  Osteoporosis in men.

Authors:  Sundeep Khosla; Shreyasee Amin; Eric Orwoll
Journal:  Endocr Rev       Date:  2008-05-01       Impact factor: 19.871

Review 9.  Androgen replacement therapy: present and future.

Authors:  Louis J G Gooren; Mathijs C M Bunck
Journal:  Drugs       Date:  2004       Impact factor: 9.546

10.  Insulin-like growth factor-II is increased in systemic sclerosis-associated pulmonary fibrosis and contributes to the fibrotic process via Jun N-terminal kinase- and phosphatidylinositol-3 kinase-dependent pathways.

Authors:  Eileen Hsu; Carol A Feghali-Bostwick
Journal:  Am J Pathol       Date:  2008-05-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.